Evidence map›Paper›PMID 39169740›Full record

ArticleThe Journal of neuropsychiatry and clinical neurosciences2025

Race-Ethnicity, Rurality, and Age in Prospective Preferences and Concerns Regarding Closed-Loop Implanted Neural Devices.

Bryan B Chen, Tobias Haeusermann, Abraham Dada, Roy H Hamilton, Jennifer E James, Kristina Celeste Fong, Daniel Dohan, Winston Chiong

Abstract read
In one paragraph

Article in The Journal of neuropsychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Ethical considerations in rapid and novel treatments in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bryan B ChenMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).
Tobias HaeusermannMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).
Abraham DadaMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).
Roy H HamiltonMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).
Jennifer E JamesMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).
Kristina Celeste FongMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).
Daniel DohanMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).
Winston ChiongMemory and Aging Center (Chen, Haeusermann, Dada, Fong, Chiong), School of Nursing (James), and Institute for Health Policy Studies (Dohan), University of California, San Francisco; Department of Neurology, University of Pennsylvania, Philadelphia (Hamilton).

Funding

VARC CoreP30AG044281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alexander Keliimoeanu Smith · 2013 to 2026
$19.9M
Anticipating ethical challenges and disparities in the dissemination of novel neurotechnologiesR01MH126997 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIONG, WINSTON, DOHAN, DANIEL P. · 2021 to 2024
$1.7M
NIA NIH HHS P30 AG044281NIMH NIH HHS R01 MH126997
6 · The paper itself

Abstract

objectiveResponsive and human-centered neurotechnology development requires attention to public perceptions, particularly among groups underserved by existing treatments.

methodsThe authors conducted a preregistered nationally representative survey (https://osf.io/ej9h2) using the NORC at the University of Chicago AmeriSpeak panel. One vignette compared an implanted neural device with surgical resection in a scenario involving epilepsy, and another compared an implanted neural device with medications in a scenario involving mood disorders. The survey also contained questions about respondents' confidence that a device would be available if needed and confidence that enough research has been conducted among people like themselves. Responses were entered into nested survey-weighted logistic regression models, including a base demographic model (to test the overall effect of demographic factors) and an adjusted model that also included socioeconomic, religious and political, and health care access predictors.

resultsA total of 1,047 adults responded to the survey, which oversampled Black non-Hispanic (N=214), Hispanic (N=210), and rural (N=219) Americans. In the base demographic model, older Americans were more likely to prefer an implanted device in the two scenarios, and non-Hispanic Black Americans were less likely than non-Hispanic White Americans to prefer a device; rural Americans were less confident than urban or suburban Americans in having access, and non-Hispanic Black and rural Americans were less confident that enough research has been conducted among people like themselves. In adjusted models, income was a key mediator, partially explaining the effect of age and the contrast between Black and White non-Hispanic respondents on preferences for a device in the epilepsy scenario and fully explaining the effect of rurality on confidence in access.

conclusionsDemographic differences in prospective preferences and concerns highlight the importance of including members of underserved communities in neurotechnology development.

Indexed as

EpilepsyPatient PreferenceRural PopulationAdolescentAdultAgedAge FactorsBlack or African AmericanEthnicityFemaleHispanic or LatinoHumansMaleMiddle AgedRacial GroupsUnited StatesEpilepsyEthicsImplanted Neural DevicesNeurotechnologyStatisticsUnderserved Communities

Identifiers

PMID39169740
PMCPMC11969628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.